S
32.91
0.15 (0.46%)
| Previous Close | 32.76 |
| Open | 33.00 |
| Volume | 1,307,834 |
| Avg. Volume (3M) | 1,172,303 |
| Market Cap | 3,121,849,088 |
| Price / Sales | 13.14 |
| Price / Book | 13.05 |
| 52 Weeks Range | |
| Earnings Date | 5 May 2025 - 9 May 2025 |
| Diluted EPS (TTM) | -2.55 |
| Total Debt/Equity (MRQ) | 20.22% |
| Current Ratio (MRQ) | 10.25 |
| Operating Cash Flow (TTM) | -229.84 M |
| Levered Free Cash Flow (TTM) | -134.32 M |
| Return on Assets (TTM) | -50.15% |
| Return on Equity (TTM) | -106.71% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bearish |
| Biotechnology (Global) | Mixed | Bearish | |
| Stock | Scholar Rock Holding Corporatio | Bullish | Bullish |
AIStockmoo Score
2.0
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | -0.5 |
| Average | 2.00 |
|
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 4.35% |
| % Held by Institutions | 118.63% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 50.00 (Jefferies, 51.93%) | Buy |
| Median | 45.00 (36.74%) | |
| Low | 45.00 (Barclays, 36.74%) | Buy |
| 45.00 (BMO Capital, 36.74%) | Buy | |
| Average | 46.67 (41.81%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 32.55 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 17 Sep 2025 | 45.00 (36.74%) | Buy | 31.67 |
| Jefferies | 21 Aug 2025 | 50.00 (51.93%) | Buy | 34.59 |
| BMO Capital | 07 Aug 2025 | 45.00 (36.74%) | Buy | 31.40 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |